Case 5-2006 Recombinant Factor VIIa in the Management of Postoperative Bleeding After Repair for Inadvertently Thrombolysed Acute Type A Aortic Dissection

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 5, 2006, Pages 736-741

  Faber, Peter ^a   Reid, Colin ^a   El Shafei, Hussein ^a   Falase, Bode ^a   DeAnda Jr , Abe ^b   Mazer, C David ^c  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

recombinant factor VIIa; thrombolysis; type A aortic dissection

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; HEPARIN; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; AORTA DISSECTION; ARTICLE; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; CARDIAC PATIENT; CASE REPORT; COMMUNITY HOSPITAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMAN; INTENSIVE CARE UNIT; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THORAX PAIN; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY;

ACUTE DISEASE; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; FACTOR VII; FACTOR VIIA; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR SURGICAL PROCEDURES;

EID: 33749116919     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.05.017     Document Type: Article

References (32)

1. Tsai H.W., Hsieh S.R., Wei H.J., et al. Determinants of in-hospital mortality after surgery for acute type A aortic dissection. J Formos Med Assoc 103 (2004) 428-431
2. Karkouti K., Wijeysundera D.N., Yau T.M., et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 44 (2004) 1453-1462
3. Takarabe K., Ohtsubo S., Itoh T., et al. Improved survival of surgery for acute type A aortic dissection: Impact of noninvasive diagnosis and haemostatic surgical management. Jpn J Thorac Cardiovasc Surg 52 (2004) 57-64
4. Woodman R.C., and Harker L.A. Bleeding complications associated with cardiopulmonary bypass. Blood 76 (1990) 1680-1697
5. Eikelboom J.W., Bird R., Blythe D., et al. Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 14 (2003) 713-717
6. Aggarwal A., Malkovska V., Catlett J.P., et al. Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable haemorrhage from cardiac surgery and other causes. Thromb J 2 (2004) 9
7. von Kodolitsch Y., Schwartz A.G., and Nienaber C.A. Clinical prediction of acute aortic dissection. Arch Intern Med 160 (2000) 2977-2982
8. Eggebrecht H., Naber C.K., Bruch C., et al. Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol 44 (2004) 804-809
9. Monroe D.M., Hoffman M., Oliver J.A., et al. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99 (1997) 542-547
10. Henderson M. Recombinant activated factor VII in cardiac surgery. Blood Coagul Fibrinolysis 15 suppl 1 (2004) S31-S32
11. Trimarchi S., Nienaber C.A., Rampoli V., et al. Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience. J Thorac Cardiovasc Surg 129 (2005) 112-122
12. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 Update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 (1999) 890-911
13. The Thrombolysis in Myocardial Ischemia (TIMI)-IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of TIMI IIIB Trial. Circulation 89 (1994) 1545-1556
14. Ross A.M. New plasminogen activators: A clinical review. Clin Cardiol 22 (1999) 165-171
15. Flynn J.D., Pajoumand M., Camp P.C., et al. Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation. Ann Pharmacother 38 (2004) 1639-1642
16. Flynn J.D., Camp P.C., Jahania M.S., et al. Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII. ASAIO J 50 (2004) 519-521
17. von Heymann C., Schoenfeld H., Sander M., et al. Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: A rationale for the use of coagulation factor concentrates?. Heart Surg Forum 8 (2005) E39-E41
18. McIlroy D.R., and Silvers A.J. Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin. Anesth Analg 99 (2004) 27-30
19. Kamp T.J., Goldschmidt-Clermont P.J., Brinker J.A., et al. Myocardial infarction, aortic dissection, and thrombolytic therapy. Am Heart J 128 (1994) 1234-1237
20. Tanswell P., Modi N., Combs D., et al. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet 41 (2002) 1229-1245
21. Tanaka M., Kawahito K., Adachi H., et al. Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method. J Thorac Cardiovasc Surg 126 (2003) 837-841
22. ten Cate J.W., Timmers H., and Becker A.E. Coagulopathy in ruptured or dissecting aortic aneurysms. Am J Med 59 (1975) 171-176
23. Nakajima T., Kin H., Minagawa Y., et al. Coagulopathy associated with residual dissection after surgical treatment of type A aortic dissection. J Vasc Surg 26 (1997) 609-615
24. Naik V.N., Mazer C.D., Latter D.A., et al. Successful treatment using recombinant factor VIIa for severe bleeding post-cardiopulmonary bypass. Can J Anaesth 50 (2003) 599-602
25. Diprose P., Herbertson M.J., O'Shaughnessy D., et al. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex noncoronary cardiac surgery: Randomized double-blind placebo-controlled pilot study. Br J Anaesth 95 (2005) 596-602
26. Raivio P., Suojaranta-Ylinen R., and Kuitunen A.H. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 80 (2005) 66-71
27. Hendriks H.G., Meijer K., de Wolf J.T., et al. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 13 (2002) 309-313
28. Carr Jr. M.E., Martin E.J., Kuhn J.G., et al. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa. Clin Lab 50 (2004) 529-538
29. Sorensen B., and Ingerslev J. Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin Hematol 41 suppl 1 (2004) 140-144
30. Karkouti K., Beattie W.S., Wijeysundera D.N., et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis. Transfusion 45 (2005) 26-34
31. Mayer S.A., Brun N.C., Begtrup K., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 24 (2005) 777-785
32. O'Connell K.A., Wood J.J., Wise R.P., et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 18 (2006) 293-298